📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Sphingolipids as targets for inhalation treatment of cystic fibrosis. (2018)

First Author: Becker KA

Attributed to: Newcastle Confidence in Concept 2016 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.addr.2018.04.015

PubMed Identifier: 29698625

Publication URI: http://europepmc.org/abstract/MED/29698625

Type: Journal Article/Review

Volume: 133

Parent Publication: Advanced drug delivery reviews

ISSN: 0169-409X